Research advances of standardized application of somatostatin after abdominal operation
10.3760/cma.j.cn115610-20240506-00235
- VernacularTitle:腹部手术生长抑素类药物规范应用的研究进展
- Author:
Taiping ZHANG
1
;
Chaowu CHEN
;
Fei LI
;
Qun ZHANG
;
Hongqi LI
Author Information
1. 中国医学科学院 北京协和医学院 北京协和医院基本外科，北京 100730
- Keywords:
Abdominal operation;
Somatostatin;
Standardized application;
Digestive surgery;
Research advances
- From:
Chinese Journal of Digestive Surgery
2024;23(5):676-679
- CountryChina
- Language:Chinese
-
Abstract:
Abdominal surgery as a common type of clinical surgery, postoperative treat-ment and rehabilitation has always been the focus of surgeons. Somatostatin drugs are commonly used for postoperative bleeding, portal hypertension bleeding, and prophylactic treatment of com-plications such as acute pancreatitis. However, the standardized application of somatostatin still faces numerous challenges in clinical practice. The famous experts and their teams in the field of digestive surgery, medical insurance expert and lawyer, combined with the experience of their respective centers, under the new national medical insurance policy, explore the significance of treatment and rehabilitation after abdominal surgery and the application strategy of somatostatin drugs from different angles. Professor Zhang Taiping succinctly explained the incidence and harm of gastro-intestinal fistula, pointing out that "how to heal the fistula in a short time" is the main rehabilitation goal and the treatment is mainly comprehensive treatment. Professor Chen Chaowu comprehen-sively introduces diagnostic and treatment processes for several representative cases encountered in clinical practice while sharing his team′s rich clinical experience and posing reflective questions. Professor Li Fei starts with practical cases, focusing on duodenal fistula, including fistula caused by complications after endoscopic retrograde cholangiopancreatography, with special emphasis on Stanford classification and different types of treatment. Ms. Zhang Qun interprets national medical insurance policies. She emphasizes the significance of supervising medical insurance funds and shares experiences related to issues regarding autonomous management by healthcare institutions. Lawyer Li Hongqi provides comprehensive suggestions on rational use of drug based on policy guidance and practical cases.
